rs3774473

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000720.4(CACNA1D):​c.484-45955G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.105 in 152,148 control chromosomes in the GnomAD database, including 874 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.10 ( 874 hom., cov: 32)

Consequence

CACNA1D
NM_000720.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.491

Publications

11 publications found
Variant links:
Genes affected
CACNA1D (HGNC:1391): (calcium voltage-gated channel subunit alpha1 D) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, namely alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1D subunit. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
CACNA1D Gene-Disease associations (from GenCC):
  • aldosterone-producing adenoma with seizures and neurological abnormalities
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Illumina, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • sinoatrial node dysfunction and deafness
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.166 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000720.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1D
NM_000720.4
MANE Plus Clinical
c.484-45955G>A
intron
N/ANP_000711.1
CACNA1D
NM_001128840.3
MANE Select
c.484-45955G>A
intron
N/ANP_001122312.1
CACNA1D
NM_001128839.3
c.484-45955G>A
intron
N/ANP_001122311.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1D
ENST00000288139.11
TSL:1 MANE Plus Clinical
c.484-45955G>A
intron
N/AENSP00000288139.3
CACNA1D
ENST00000350061.11
TSL:1 MANE Select
c.484-45955G>A
intron
N/AENSP00000288133.5
CACNA1D
ENST00000481478.2
TSL:1
c.484-45955G>A
intron
N/AENSP00000418014.2

Frequencies

GnomAD3 genomes
AF:
0.105
AC:
15908
AN:
152028
Hom.:
875
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.114
Gnomad AMI
AF:
0.0998
Gnomad AMR
AF:
0.127
Gnomad ASJ
AF:
0.0430
Gnomad EAS
AF:
0.175
Gnomad SAS
AF:
0.114
Gnomad FIN
AF:
0.0816
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.0950
Gnomad OTH
AF:
0.0981
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.105
AC:
15914
AN:
152148
Hom.:
874
Cov.:
32
AF XY:
0.104
AC XY:
7762
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.114
AC:
4734
AN:
41504
American (AMR)
AF:
0.128
AC:
1947
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.0430
AC:
149
AN:
3468
East Asian (EAS)
AF:
0.175
AC:
905
AN:
5168
South Asian (SAS)
AF:
0.114
AC:
548
AN:
4820
European-Finnish (FIN)
AF:
0.0816
AC:
866
AN:
10614
Middle Eastern (MID)
AF:
0.0476
AC:
14
AN:
294
European-Non Finnish (NFE)
AF:
0.0950
AC:
6458
AN:
67986
Other (OTH)
AF:
0.0956
AC:
202
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
720
1440
2161
2881
3601
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
178
356
534
712
890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0984
Hom.:
2781
Bravo
AF:
0.109
Asia WGS
AF:
0.135
AC:
468
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.46
DANN
Benign
0.58
PhyloP100
-0.49
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3774473; hg19: chr3-53638851; API